Scarica l'app Stockscreener
478.81
0.09%
0.4852
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$478.32
Aprire:
$475.44
Volume 24 ore:
523.87K
Relative Volume:
0.19
Capitalizzazione di mercato:
$180.68B
Reddito:
$43.21B
Utile/perdita netta:
$6.58B
Rapporto P/E:
27.69
EPS:
17.29
Flusso di cassa netto:
$6.17B
1 W Prestazione:
+18.23%
1M Prestazione:
+17.27%
6M Prestazione:
-18.06%
1 anno Prestazione:
-21.14%
Intervallo 1D:
$474.87
$480.57
Intervallo di 1 settimana:
$405.15
$484.60
Portata 52W:
$385.46
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Confronta TMO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
478.63 | 180.56B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
204.50 | 147.13B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
567.69 | 45.45B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
119.98 | 34.14B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
198.07 | 33.86B | 15.50B | 1.33B | 2.16B | 7.34 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher Scientific Showcases Diagnostics Solutions Designed to Meet Evolving Global Healthcare Demands at ADLM 2025 - Bluefield Daily Telegraph
Cell Reprogramming Market Future Business Opportunities - openPR.com
Thermo Fisher Scientific's (TMO) Q2 Outperformance and Revised Price Target: Is Now the Time to Buy? - AInvest
Refurbished Laboratory Equipment Market Top Companies Study - openPR.com
Barclays Lifts PT on Thermo Fisher Scientific (TMO) to $490 From $450 - Insider Monkey
TD Cowen Sees Upside for Thermo Fisher (TMO) With Modest Q2 Growth - Insider Monkey
When is Thermo Fisher Scientific Inc. stock expected to show significant growthDiscover high-impact investment opportunities - jammulinksnews.com
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio? - Benzinga
Thermo Fisher Scientific Inc. (TMO) Has Finally Got It Together, Says Jim Cramer - MSN
Evercore ISI Raises PT on Thermo Fisher Scientific (TMO) to $525 From $480 - MSN
Is Thermo Fisher Scientific Inc. a good long term investmentFree Stock Index Interpretation - PrintWeekIndia
Trade Deals Fuel Wall Street Gains, Trump Renews Fed Attack: This Week In Markets - Benzinga
Thermo Fisher Scientific (TMO) Unveils New Microscopes At M&M Conference - Yahoo Finance
Fortune 500 Power Moves: Which executives gained and lost power this week, July 19-25, 2025 - Fortune
Thermo Fisher Unit Can’t Undo Executive’s $24 Million Bias Win - Bloomberg Law News
Analyst recommendations: Thermo Fisher Scientific, Intel, Honeywell International, Union Pacific, Gilead Sciences... - MarketScreener
Thermo Fisher Scientific Second Quarter 2025 Earnings: Beats Expectations - simplywall.st
Microplate Readers Market Is Booming So Rapidly 2025-2032 - openPR.com
Thermo Fisher Scientific Increases Accessibility to Research with the Launches of Scios 3 and Talos 12 Electron Microscopes at M&M 2025 Conference - AZoM
ICP-MS System Market Key Players AnalysisPerkinElmer, Inc., - openPR.com
Stifel lowers Thermo Fisher Scientific stock price target to $583 on mixed outlook - Investing.com Canada
What analysts say about Thermo Fisher Scientific Inc. stock outlookRapid wealth multiplication - jammulinksnews.com
HSBC downgrades Thermo Fisher Scientific stock to Hold on growth concerns - Investing.com
Thermo Fisher Scientific Increases Accessibility to Research With the Launches of Scios 3 and Talos 12 Electron Microscopes at M&M 2025 Conference - StreetInsider
Thermo Fisher Scientific Inc. Ranks 19th in Trading Volume Despite 17.31% Stock Gain in Three Days - AInvest
[Latest] Global CRISPR Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Yahoo Finance
UBS Maintains Neutral Rating for Thermo Fisher, Raises PT to $500 from $460 - AInvest
Thermo Fisher Scientific shares rise 2.73% intraday after announcing new electron microscopes and licensing agreement expansion. - AInvest
Thermo Fisher CFO to retire after decade, internal successor named - The Business Journals
Bernstein raises Thermo Fisher Scientific stock price target on pharma R&D strength - Investing.com
Analyst recommendations: Alphabet, IBM, Thermo Fisher Scientific, Lockheed Martin, ServiceNow... - MarketScreener
Thermo Fisher Scientific Inc. (NYSE:TMO) Q2 2025 Earnings Call Transcript - Insider Monkey
Thermo Fisher Scientific Q2 2025 revenue up 3% to USD 10.85B - Medical Buyer
Company News for Jul 24, 2025 - The Globe and Mail
Research Alert: CFRA Keeps Buy Recommendation On Shares Of Thermo Fisher Scientific Inc. - 富途牛牛
Thermo Fisher Scientific Inc (TMO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
Thermo Fisher Scientific’s Chief Financial Officer, Stephen Williamson, to Retire in Early 2026 - BioSpace
Thermo Fisher Scientific Reports Steady Q2 2025 Growth - TipRanks
Thermo Fisher Scientific's Revised Outlook: A Catalyst for Long-Term Growth in Life Sciences and Diagnostics - AInvest
Thermo Fisher: Q2 Earnings Snapshot - Norwalk Hour
Thermo Fisher Scientific's Q3 2025 Earnings: Assessing Growth Sustainability Amid Life Sciences Surge - AInvest
Thermo Fisher Q2 Revenue Exceeds Estimates, Shares Surge 12% Amid Strong Life Sciences and Diagnostics Demand - AInvest
Thermo Fisher’s Earnings Call Highlights Growth and Challenges - TipRanks
Thermo Fisher Scientific announces CFO retirement and successor appointment - Investing.com
Thermo Fisher Announces CFO Retirement and Successor - TipRanks
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
TMO announces CFO retirement & internal successor effective 2026 | TMO SEC FilingForm 8-K - Stock Titan
Why Thermo Fischer Stock Is Rising Wednesday - AOL.com
Growth or Bubble? Thermo Fisher’s Market Moves - StocksToTrade
Thermo Fisher's Strong Q2 Performance and Revised Guidance: A Buy Signal Amid a Challenging Sector? - AInvest
Thermo Fisher Scientific (TMO) Reports Earnings Increase and Announces CFO Transition - simplywall.st
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
0.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):